Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Esperion Therapeutics Inc. (NASDAQ: ESPR) closed at $1.97 up 4.23% from its previous closing price of $1.89. In other words, the price has increased by $4.23 from its previous closing price. On the day, 3.46 million shares were traded. ESPR stock price reached its highest trading level at $1.98 during the session, while it also had its lowest trading level at $1.885.
Ratios:
For a deeper understanding of Esperion Therapeutics Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.49 and its Current Ratio is at 1.97.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 17 ’24 when Koenig Sheldon L. sold 14,550 shares for $1.80 per share. The transaction valued at 26,132 led to the insider holds 752,266 shares of the business.
Warren Eric sold 2,608 shares of ESPR for $4,650 on Sep 17 ’24. The Chief Commercial Officer now owns 162,659 shares after completing the transaction at $1.78 per share. On Sep 17 ’24, another insider, Foody Joanne M., who serves as the Officer of the company, bought 3,381 shares for $1.78 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESPR now has a Market Capitalization of 386563232 and an Enterprise Value of 466393664. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.39. Its current Enterprise Value per Revenue stands at 1.679 whereas that against EBITDA is 93.466.
Stock Price History:
Over the past 52 weeks, ESPR has reached a high of $3.40, while it has fallen to a 52-week low of $0.70. The 50-Day Moving Average of the stock is 8.05%, while the 200-Day Moving Average is calculated to be -12.83%.
Shares Statistics:
For the past three months, ESPR has traded an average of 4.02M shares per day and 3941670 over the past ten days. A total of 196.22M shares are outstanding, with a floating share count of 194.16M. Insiders hold about 1.05% of the company’s shares, while institutions hold 72.26% stake in the company. Shares short for ESPR as of 1727654400 were 37467113 with a Short Ratio of 9.32, compared to 1724976000 on 40438871. Therefore, it implies a Short% of Shares Outstanding of 37467113 and a Short% of Float of 19.139999.
